
Use of bisphenol A - a plastic chemical may expose unborn children to breast cancer later in life, warns France's food safety agency.
Bisphenol A, or BPA, is a common component of plastic bottles and canned food and drink linings, but some studies have linked it to brain and nervous system problems, reproductive disorders and obesity.
Advertisement
The ANSES agency urged pregnant women to avoid food preserved in cans, or drinking water from polycarbonate water fountains found in many office buildings which it said was a "source of exposure to bisphenol A".
It also advised them to avoid handling till slips.
The agency said bisphenol A could be dangerous if ingested, inhaled or simply by touching products that contain it -- including thermal paper like that used to make cash register slips.
In a report summarising several global scientific studies on the topic up to July 2012, ANSES said its experts were "moderately" confident of the evidence pointing to a risk to babies in the womb.
"The conclusions show that certain exposure of pregnant women to BPA poses a risk for the mammary glands of the unborn child," the agency said in a report that wrapped up a three-year investigation.
The risk "may be characterised... by increased sensitivity of the mammary gland to the formation of tumours. The risk potentially concerns both sexes," said the report.
ANSES stressed there were still many uncertainties in the data.
Advised by agencies like ANSES, the French parliament in December voted to ban BPA's use in baby food packaging from 2013 and in all food containers from 2015.
The European Union, United States and Canada have outlawed its use in baby bottles.
The chemical is still used around the world in plastic products, and the United States said last year it would not impose a general ban of BPA as there was no evidence of harm to adults.
ANSES also cautioned against replacing bisphenol A with a substitute from the same chemical family, saying not enough was known about other bisphenols like M, S, B, AP, AF, F and BADGE.
"These substances share a chemical structure," the agency pointed out.
Source: AFP
The agency said bisphenol A could be dangerous if ingested, inhaled or simply by touching products that contain it -- including thermal paper like that used to make cash register slips.
Advertisement
In a report summarising several global scientific studies on the topic up to July 2012, ANSES said its experts were "moderately" confident of the evidence pointing to a risk to babies in the womb.
"The conclusions show that certain exposure of pregnant women to BPA poses a risk for the mammary glands of the unborn child," the agency said in a report that wrapped up a three-year investigation.
The risk "may be characterised... by increased sensitivity of the mammary gland to the formation of tumours. The risk potentially concerns both sexes," said the report.
ANSES stressed there were still many uncertainties in the data.
Advised by agencies like ANSES, the French parliament in December voted to ban BPA's use in baby food packaging from 2013 and in all food containers from 2015.
The European Union, United States and Canada have outlawed its use in baby bottles.
The chemical is still used around the world in plastic products, and the United States said last year it would not impose a general ban of BPA as there was no evidence of harm to adults.
ANSES also cautioned against replacing bisphenol A with a substitute from the same chemical family, saying not enough was known about other bisphenols like M, S, B, AP, AF, F and BADGE.
"These substances share a chemical structure," the agency pointed out.
Source: AFP
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.